75
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Gene-silencing effects of anti-survivin siRNA delivered by RGDV-functionalized nanodiamond carrier in the breast carcinoma cell line MCF-7

, , , &
Pages 5771-5787 | Published online: 04 Nov 2016

References

  • HanahanDWeinbergRAThe hallmarks of cancerCell20001001577010647931
  • ElbashirSMHarborthJLendeckelWYalcinAWeberKTuschlTDuplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cellsNature2001411683649449811373684
  • HannonGJRNA interferenceNature2002418689424425112110901
  • HutvágnerGZamorePDRNAi: nature abhors a double-strandCurr Opin Genet Dev200212222523211893497
  • WangYLiZHanYLiangLHJiANanoparticle-based delivery system for application of siRNA in vivoCurr Drug Metab201011218219620359287
  • AliabadiHMLandryBSunCTangTUludağHSupramolecular assemblies in functional siRNA delivery: where do we stand?Biomaterials20123382546256922209641
  • Lo MuzioLPannoneGLeonardiRSurvivin, a potential early predictor of tumor progression in the oral mucosaJ Dent Res2003821192392814578507
  • AbeTGodaKFutamiKFuruichiYDetection of siRNA administered to cells and animals by using a fluorescence intensity distribution analysis polarization systemNucleic Acids Res2009377e5619282452
  • ThakurAFitzpatrickSZamanAStrategies for ocular siRNA delivery: potential and limitations of non-viral nanocarriersJ Biol Eng20126722686441
  • ContiDSBrewerDGrashikJAvasaralaSda RochaSRPoly(amidoamine) dendrimer nanocarriers and their aerosol formulations for siRNA delivery to the lung epitheliumMol Pharm20141161808182224811243
  • TrabuloSCardosoAMSantos-FerreiraTCardosoALSimõesSPedroso de LimaMCSurvivin silencing as a promising strategy to enhance the sensitivity of cancer cells to chemotherapeutic agentsMol Pharm2011841120113121619051
  • AltieriDCSurvivin – the inconvenient IAPSemin Cell Dev Biol201539919625591986
  • TammIWangYSausvilleEIAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugsCancer Res19985823531553209850056
  • AmbrosiniGAdidaCAltieriDCA novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNat Med1997389179219256286
  • WangTTQianXPLiuBRSurvivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancerWorld J Gastroenterol200713202784279017569112
  • SmolewskiPRobakTInhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignanciesCurr Mol Med201111863364921902653
  • MobahatMNarendranARiabowolKSurvivin as a preferential target for cancer therapyInt J Mol Sci20141522494251624531137
  • KimNJJiangDJacobiAMSynthesis and characterization of mannosylated pegylated polyethylenimine as a carrier for siRNAInt J Pharm2012427112313321864664
  • GuoXHuangLRecent advances in nonviral vectors for gene deliveryAcc Chem Res201245797197921870813
  • MochalinVNShenderovaOHoDGogotsiYThe properties and applications of nanodiamondsNat Nanotechnol201171112322179567
  • MansoorianfarMShokrgozarMAMehrjooMTamjidESimchiANanodiamonds for surface engineering of orthopedic implants: enhanced biocompatibility in human osteosarcoma cell cultureDiam Relat Mater201340107114
  • CuiCWangYYangKPreparation and characterization of RGDS/nanodiamond as a vector for VEGF-siRNA deliveryJ Biomed Nanotechnol2015111708026301301
  • KaurRChitandaJMMichelDLysine-functionalized nanodiamonds: synthesis, physiochemical characterization, and nucleic acid binding studiesInt J Nanomedicine201273851386622904623
  • LookJWilhelmNBriesenHVLigand-modified human serum albumin nanoparticles for enhanced gene deliveryMol Pharm20151293202321326218774
  • JinSWangYZhuHNanosized aspirin-Arg-Gly-Asp-Val: delivery of aspirin to thrombus by the target carrier Arg-Gly-Asp-Val tetrapeptideACS Nano2013797664767323931063
  • NazliCErgencTIYarYAcarHAKizilelSRGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cellsInt J Nanomedicine2011719031920
  • KaiTSchiffelersRMMolemaGKokRJRGD-based strategies for selective delivery of therapeutics and imaging agents to the tumor vasculatureDrug Resist Updates200586381402
  • El-SayKNanodiamond as a drug delivery system: applications and prospectiveJ Appl Pharm Sci2011162939
  • SheWLuoKZhangCThe potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron–doxorubicin conjugates for cancer therapyBiomaterials20123451613162323195490
  • OlariuCIYiuHHPBouffierLMultifunctional Fe3O4 nanoparticles for targeted bi-modal imaging of pancreatic cancerJ Mater Chem2011211265012659
  • PalmaRDPeetersSBaelMJVSilane ligand exchange to make hydrophobic superparamagnetic nanoparticles water-dispersibleChem Mater200719718211831
  • XuRWuCXuHParticle size and zeta potential of carbon black in liquid mediaCarbon2007451428062809
  • ThomasELaser pointer and the Tyndall effectJ Chem Educ1996735470
  • DolmatovVYDetonation-synthesis nanodiamonds: synthesis, structure, properties and applicationsCheminform20073835
  • ShimkunasRARobinsonELamRNanodiamond–insulin complexes as pH-dependent protein delivery vehiclesBiomaterials200930295720572819635632
  • ZhangXQChenMLamRXuXOsawaEHoDPolymer-functionalized nanodiamond platforms as vehicles for gene deliveryACS Nano2009392609261619719152
  • YangFHuangWLiYAnti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticlesBiomaterials201334225689569923632321
  • FicarraRFicarraPDi BellaMRStudy of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigationJ Pharm Biomed Anal2000231334010898152
  • SmithAHRobinsonEMZhangXQTriggered release of therapeutic antibodies from nanodiamond complexesNanoscale2011372844284821617824
  • KaurRBadeaINanodiamonds as novel nanomaterials for biomedical applications: drug delivery and imaging systemsInt J Nanomedicine2013820322023326195
  • SchrandAMHuangHCarlsonCAre diamond nanoparticles cytotoxic?J Phys Chem B200711112717201422
  • GiladYNoyESenderowitzHAlbeckAFirerMAGellermanGDual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cellsPeptide Sci20161062160171
  • GarateASantosEPedrazJLHernándezRMOriveGEvaluation of different RGD ligand densities in the development of cell-based drug delivery systemsJ Drug Target201523980681225816227
  • MaverUrošGodecABeleMNovel hybrid silica xerogels for stabilization and controlled release of drugInt J Pharm20073301–216417417055199
  • WangWFangCWangXModifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapyNanoscale20135146249625323680872
  • LiuSHuangWJinMJFanBXiaGMGaoZGInhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEIEur J Pharm Sci20168217118226554721
  • BeloorJChoiCSNamHYArginine-engrafted biodegradable polymer for the systemic delivery of therapeutic siRNABiomaterials20123351640165022112761
  • XieYQiaoHSuZChenMPingQSunMPEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapyBiomaterials201435277978799124939077